Evidence map›Paper›PMID 34212529›Full record

ArticleDrug testing and analysis2021

Effects of the administration of miconazole by different routes on the biomarkers of the "steroidal module" of the Athlete Biological Passport.

Monica Mazzarino, Fabio Comunità, Xavier de la Torre, Francesco Molaioni, Francesco Botrè

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Drug testing and analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Monica MazzarinoLaboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.ORCID https://orcid.org/0000-0003-2036-930X
Fabio ComunitàLaboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.
Xavier de la TorreLaboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.ORCID https://orcid.org/0000-0001-8037-6750
Francesco MolaioniLaboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.
Francesco BotrèLaboratorio Antidoping, Federazione Medico Sportiva Italiana, Rome, Italy.ORCID https://orcid.org/0000-0001-5296-8126
Federazione Medico Sportiva Italiana · IT

Funding

World Anti-Doping Agency 13D14MMWorld Anti-Doping Agency 17D07MM
6 · The paper itself

Abstract

This article reports the results obtained from the investigation of the influence of miconazole administration on the physiological fluctuation of the markers of the steroid profile included in the "steroidal module" of the Athlete Biological Passport. Urines collected from male Caucasian subjects before, during, and after either systemic (i.e., oral and buccal) or topical (i.e., dermal) treatment with miconazole were analyzed according to validated procedures based on gas chromatography coupled to tandem mass spectrometry (GC-MS/MS) (to determine the markers of the steroid profile) or liquid chromatography coupled to MS/MS (LC-MS/MS) (to determine miconazole urinary levels). The results indicate that only after systemic administration, the markers of the steroid profile were significantly altered. After oral and buccal administration, we have registered (i) a significant increase of the 5α-androstane-3α,17β-diol/5β-androstane-3α,17β-diol ratio and (ii) a significant decrease of the concentration of androsterone, etiocholanolone, 5β-androstane-3α,17β-diol, and 5α-androstane-3α,17β-diol and of the androsterone/etiocholanolone, androsterone/testosterone, and 5α-androstane-3α,17β-diol/epitestosterone ratios. Limited effects were instead measured after dermal intake. Indeed, the levels of miconazole after systemic administration were in the range of 0.1-12.5 μg/ml, whereas after dermal administration were below the limit of quantification (50 ng/ml). Significant alteration started to be registered at concentrations of miconazole higher than 0.5 μg/ml. These findings were primarily explained by the ability of miconazole in altering the kinetic/efficacy of deglucuronidation of the endogenous steroids by the enzyme β-glucuronidase during the sample preparation process. The increase of both incubation time and amount of β-glucuronidase was demonstrated to be effective countermeasures in the presence of miconazole to reduce the risk of uncorrected interpretation of the results.

Indexed as

Administration, BuccalAdministration, CutaneousAdministration, OralAdultAthletesBiomarkersChromatography, LiquidDoping in SportsGas Chromatography-Mass SpectrometryHumansMaleMiconazoleMiddle AgedSteroidsTandem Mass SpectrometryTime FactorsBiomarkersMiconazoleSteroidsantidoping analysisathletes biological passportconfounding factorsmiconazolesteroidal module

Identifiers

PMID34212529
PMCPMC8597009
OpenAlexW3175745929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.